October Effect »

Milestone Pharmaceuticals shares owned by October Effect

Quarter-by-quarter ownership of Milestone Pharmaceuticals (MIST) shares owned by October Effect from 13F filings

Historical chart of October Effect investment in Milestone Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Milestone Pharmaceuticals held by October Effect consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Milestone Pharmaceuticals by October Effect

Quarter filed Position value Share count Share price at filing
2025-12-31 $105k 52k 2.02

More positions owned by October Effect

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Spdr Series Trust State Street Spd (BIL)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Cormedix Inc cormedix (CRMD)
Proshares Tr Ultrapro Qqq (TQQQ)
Ge Aerospace Com New (GE)
Palantir Technologies Cl A (PLTR)
Ge Vernova (GEV)
Tesla Motors (TSLA)
Innovator Etfs Trust Nasdaq 100 Mana (QFLR)
Spdr Series Trust State Street Spd (SPYM)
Direxion Shs Etf Tr Drx S&p500bull (SPXL)
Insmed Com Par $.01 (INSM)
Spdr Series Trust State Street Spd (SPTI)

View all positions for October Effect

Top funds holding Milestone Pharmaceuticals

Adage Capital Partners GP
Propel Bio Management
Rtw Investments
Marshall Wace
Simplify Asset Management
Susquehanna International
Jane Street
Pathstone Holdings
Lion Point Capital
Toronto-Dominion Bank
Boxer Capital Management
Two Sigma Investments
Stonepine Capital Management
Citadel Advisors
UBS Group

View all funds holding Milestone Pharmaceuticals